Courtney Shumpert, DVM

 

 

Understanding Equine Protozoal Myleoencephalitis (EPM) 

(Part 2)
Part 1 of this article will cover definitions, disease transmission, symptoms, and horses at risk. Part 2 will focus on diagnosis, treatment, and prevention of this deadly illness.

Source: American Association of Equine Practitioners/Bayer


Equine Protozoal Myleoencephalitis (EPM) is a debilitating condition affecting the equine nervous system. 

Diagnosis

If a horse shows any neurologic abnormalities (ataxia, weakness, stumbling, dragging the toes, etc.) your veterinarian should be called. If a thorough physical examination reveals clinical signs consistent with EPM, a blood test and a cerebrospinal fluid (CSF) analysis may be used to confirm the diagnosis. It is important to remember that a positive blood test for Sarcocystis neurona only confirms exposure to the organism. This does NOT necessarily mean the horse has or will develop EPM. (Example: Most children have been exposed to chicken pox at some point, but not all will develop the disease.)

            Prompt, accurate diagnosis is essential. Treatment should begin immediately.

           

Treatment

As with any disease, the sooner the treatment is begun, the better the horse’s chances for recovery. Around 60 to 70 percent of EPM cases treated aggressively show a significant or complete reversal of symptoms.

            Until recently, there were no labeled anti-protozoal drugs approved by the FDA to treat EPM. Treatment was mainly supportive. Anti-inflammatory drugs were (and still are) used to treat symptoms and prevent reactions to the parasite die-off. Vitamin E (an antioxidant) supplementation was recommended to aid healing of nervous tissue, and Vitamin B(folic acid) supplementation was aimed at reversing the antifolate drugs often used as part of a treatment protocol . The average duration of treatment for the disease was 3-6 months, often even longer. Treatment could become extremely costly, and not all horses respond positively to therapy. Approximately 10-20% of horses may experience a relapse.

            However, these are exciting times in EPM treatment. Bayer has recently introduced the first FDA approved treatment for EPM. Marquis (ponazuril) is an antiprotozoal drug that is manufactured as an oral paste. This product is administered by mouth once a day for 28 consecutive days.

            It is important to note that while Marquis should effectively clear the horse of the causative parasite, S.neurona, it may have no effect on pre-existing CNS damage caused by the protozoa prior to treatment.


Methods of Prevention

Recent developments in the fight against EPM have yielded a new vaccine. Manufactured by Fort Dodge, this is the first vaccine of its kind. For more information on the vaccine, visit www.epmvacccine.com.

            Good horsekeeping practices should be used to discourage unwanted visitors. This includes keeping feed rooms and containers closed and sealed, using feeders that minimize spillage and are difficult for wild animals to access, and cleaning up any dropped grain immediately to discourage birds and other scavengers. Feeding heat-treated cereal grains and extruded feeds since these processes seem to kill the infective sporocysts.


Read Part 1 of this Article

RodeoPageants.com